+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microchip Electrophoresis - Global Strategic Business Report

  • PDF Icon

    Report

  • 188 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6093764
The global market for Microchip Electrophoresis was valued at US$3.3 Billion in 2025 and is projected to reach US$4.3 Billion by 2032, growing at a CAGR of 4.1% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Microchip Electrophoresis Market - Key Trends & Drivers Summarized

How Is Microchip Electrophoresis Transforming Laboratory Analysis and Diagnostics?

Microchip electrophoresis is rapidly redefining the landscape of chemical and biological separation through miniaturized platforms that enable fast, high-resolution analysis. This lab-on-a-chip technology reduces reagent consumption, increases throughput, and enables real-time analysis of nucleic acids, proteins, and small molecules. The process works by applying an electric field across microchannels etched onto a chip, allowing analytes to separate based on charge-to-mass ratio - a critical function in genomics, clinical diagnostics, and pharmaceutical quality control.

Unlike traditional gel or capillary electrophoresis, microchip systems integrate sample injection, separation, and detection onto a single compact substrate. This integration not only shortens analysis time but also enables portability - facilitating on-site testing and point-of-care diagnostics. Its compatibility with fluorescence, electrochemical, and UV detection systems makes microchip electrophoresis highly versatile across various bioanalytical and chemical applications.

What Are the Key Technical Developments Accelerating Performance and Adoption?

Recent innovations in microfabrication and material science have expanded the capabilities of microchip electrophoresis platforms. The use of glass, PDMS, and thermoplastics as chip substrates has improved chemical resistance, biocompatibility, and manufacturability. Simultaneously, advancements in 3D microchannel structuring and integrated electrokinetic pumping are enhancing separation efficiency and minimizing cross-contamination between sample paths.

Detection sensitivity is being boosted by coupling with advanced optical and electrochemical sensors, while multiplexing capabilities are expanding the number of simultaneous analyses per chip. Integration with sample preparation tools such as solid-phase extraction and microfluidic PCR is also advancing, pushing microchip electrophoresis into true lab-on-chip territory. These developments are helping address long-standing limitations in resolution, reproducibility, and device scalability.

Which Sectors Are Leading the Use of Microchip Electrophoresis Technologies?

The life sciences and pharmaceutical sectors are major adopters of microchip electrophoresis for DNA/RNA fragment analysis, protein isoform identification, and drug impurity profiling. Clinical laboratories use these platforms for quick screening of infectious agents, cancer biomarkers, and metabolic profiles. In forensic science, the rapid and portable nature of microchip electrophoresis enables in-field DNA analysis and toxicological screening.

Environmental agencies are leveraging the technology to monitor water quality and detect trace contaminants. Food and beverage industries employ microchip electrophoresis to ensure compliance with safety standards by identifying allergens, preservatives, and contaminants in product samples. This broadening application base is creating a robust demand for tailored chip designs and integrated systems that meet the specific needs of each vertical.

The Growth in the Microchip Electrophoresis Market Is Driven by Several Factors

The growth in the microchip electrophoresis market is driven by several factors including the rising demand for rapid diagnostics, increasing use in pharmaceutical R&D, and the shift toward point-of-care testing platforms. Technological innovations in microchannel design, chip integration, and multi-analyte detection are enhancing speed, sensitivity, and operational flexibility. The miniaturization of bioanalytical tools for remote, real-time monitoring in healthcare and environmental diagnostics is also boosting market traction. As lab automation and personalized medicine evolve, microchip electrophoresis is positioned to become a foundational analytical platform in next-generation laboratory and field testing environments.

Report Scope

The report analyzes the Microchip Electrophoresis market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: End-Use (Railways, Battery Storage, EV Charger, Power Generation)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Railways segment, which is expected to reach US$1.8 Billion by 2032 with a CAGR of a 3.7%. The Battery Storage segment is also set to grow at 3.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $885.7 Million in 2025, and China, forecasted to grow at an impressive 7.0% CAGR to reach $879.4 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Microchip Electrophoresis Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Microchip Electrophoresis Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Microchip Electrophoresis Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, C.B.S. Scientific Company, ChipShop and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Microchip Electrophoresis market report include:

  • Agilent Technologies
  • Analytik Jena
  • Bio-Rad Laboratories
  • C.B.S. Scientific Company
  • ChipShop
  • Danaher Corporation
  • Didac International
  • GE Healthcare
  • Harvard Bioscience
  • Helena Laboratories
  • LabSmith
  • Lonza Group
  • Merck KGaA
  • Micronit
  • MicruX Technologies
  • PerkinElmer
  • Promega Corporation
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Microchips in Medicine - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Development of Smart Pills and Ingestible Microchips Throws the Spotlight on Digital Medicine
  • Rising Need for Continuous Patient Monitoring Drives Adoption of Implantable Microchips
  • Advances in Biocompatible Semiconductor Materials Enhance Medical Integration of Microchips
  • Growth in Remote Patient Management Solutions Spurs Demand for Chip-Enabled Wearable Devices
  • Use of Microchips for Drug Release Timing Enhances Precision Therapy Protocols
  • Surge in Interest in Digital Biomarkers Expands Use of Embedded Chips for Vital Sign Capture
  • Integration of NFC and RFID Technologies Drives Development of Smart Packaging in Pharma
  • Expansion of Electronic Health Monitoring Systems Strengthens Business Case for Chip-Enabled Devices
  • Innovation in Energy Harvesting and Wireless Charging Enhances Microchip Usability in Medicine
  • Growing Investment in Neurotechnology Spurs Development of Brain-Implanted Monitoring Chips
  • Advances in Lab-on-Chip Diagnostics Drive Miniaturized Point-of-Care Testing Applications
  • Regulatory Approvals for Ingestible Sensors Expand Commercialization of Diagnostic Microchips
  • Collaborations with Pharma Firms Accelerate Development of Companion Diagnostics Using Chips
  • Increase in Clinical Trials Using Sensor-Based Monitoring Enhances Microchip Market Penetration
  • Focus on AI Integration Within Chipsets Supports Personalized and Predictive Healthcare
  • Growth in Geriatric Care Needs Propels Use of Monitoring Chips in Long-Term Care Settings
  • Use of Blockchain and Smart Contracts in Chip-Enabled Drug Traceability Strengthens Compliance
  • Expansion of Telehealth Infrastructure Globally Spurs Use of Chip-Based Mobile Health Devices
  • Development of Closed-Loop Drug Delivery Systems Integrates Microchips for Feedback Control
  • Public Acceptance of Biometric Implants Opens Pathways for Wider Use of Microchips in Medicine
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Microchips in Medicine Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Microchips in Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Drug Delivery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Drug Delivery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Home Monitoring Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Home Monitoring Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Research Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Research Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 24: USA Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: USA 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 26: USA Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 27: USA Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: USA 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 30: Canada Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: Canada 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 32: Canada Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 33: Canada Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: Canada 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
JAPAN
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 36: Japan Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: Japan 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 38: Japan Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 39: Japan Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: Japan 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
CHINA
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 42: China Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 43: China 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 44: China Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 45: China Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 46: China 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
EUROPE
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 48: Europe Historic Review for Microchips in Medicine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 49: Europe 13-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 50: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 51: Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 52: Europe 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 53: Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 54: Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 55: Europe 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
FRANCE
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 57: France Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 58: France 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 59: France Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 60: France Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 61: France 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
GERMANY
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 63: Germany Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 64: Germany 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 65: Germany Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 66: Germany Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 67: Germany 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 69: Italy Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 70: Italy 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 71: Italy Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 72: Italy Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 73: Italy 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 75: UK Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 76: UK 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 77: UK Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 78: UK Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 79: UK 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 81: Spain Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 82: Spain 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 83: Spain Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 84: Spain Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 85: Spain 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 87: Russia Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 88: Russia 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 89: Russia Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 90: Russia Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 91: Russia 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 93: Rest of Europe Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 94: Rest of Europe 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 96: Rest of Europe Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 97: Rest of Europe 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
ASIA-PACIFIC
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Microchips in Medicine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 100: Asia-Pacific 13-Year Perspective for Microchips in Medicine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Microchips in Medicine by Application - Drug Delivery Application, Home Monitoring Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 103: Asia-Pacific 13-Year Perspective for Microchips in Medicine by Application - Percentage Breakdown of Value Sales for Drug Delivery Application, Home Monitoring Application and Other Applications for the Years 2020, 2026 & 2032
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Microchips in Medicine by End-Use - Hospitals End-Use, Research Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 106: Asia-Pacific 13-Year Perspective for Microchips in Medicine by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Centers End-Use and Other End-Uses for the Years 2020, 2026 & 2032
AUSTRALIA
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Microchips in Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies
  • Analytik Jena
  • Bio-Rad Laboratories
  • C.B.S. Scientific Company
  • ChipShop
  • Danaher Corporation
  • Didac International
  • GE Healthcare
  • Harvard Bioscience
  • Helena Laboratories
  • LabSmith
  • Lonza Group
  • Merck KGaA
  • Micronit
  • MicruX Technologies
  • PerkinElmer
  • Promega Corporation
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific

Table Information